Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.

Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC). The studies are quite heterogenous regarding study size and populations, and a synopsis of these dat...

Full description

Bibliographic Details
Main Authors: Xiaofeng Chen, Yiqian Liu, Oluf Dimitri Røe, Yingying Qian, Renhua Guo, Lingjun Zhu, Yongmei Yin, Yongqian Shu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3605444?pdf=render

Internet

http://europepmc.org/articles/PMC3605444?pdf=render

Similar Items